Stifel Financial Corp Eli Lilly & CO Transaction History

Stifel Financial Corp

$85.8 Billion
Q1 2024

A detailed history of Stifel Financial Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Stifel Financial Corp holds 727,985 shares of LLY stock, worth $659 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

727,985

Previous 716,316 1.63%

Holding current value

$659 Million

Previous $418 Million 35.63%

% of portfolio

0.66%

Previous 0.54%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $6.91 Million - $9.25 Million	11,669 Added 1.63%	727,985 $566 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $8.32 Million - $9.81 Million	15,837 Added 2.26%	716,316 $418 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $6.81 Million - $9.38 Million	-15,656 Reduced 2.19%	700,479 $376 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $18.4 Million - $24.6 Million	-52,411 Reduced 6.82%	716,135 $336 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $3.86 Million - $4.53 Million	-12,419 Reduced 1.59%	768,546 $264 Million

Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $9.34 Million - $10.9 Million	29,057 Added 3.86%	780,965 $286 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $4.77 Million - $5.43 Million	16,072 Added 2.18%	751,908 $243 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $10.2 Million - $11.9 Million	36,438 Added 5.21%	735,836 $239 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $16 Million - $19.8 Million	68,046 Added 10.78%	699,398 $200 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $37.8 Million - $46.9 Million	168,123 Added 36.29%	631,352 $174 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $2.41 Million - $2.96 Million	-10,862 Reduced 2.29%	463,229 $107 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $6.85 Million - $8.86 Million	37,957 Added 8.7%	474,091 $109 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $5.17 Million - $6.69 Million	31,433 Added 7.77%	436,134 $81.5 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $3.11 Million - $4.11 Million	23,837 Added 6.26%	404,701 $68.3 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $4.92 Million - $5.69 Million	33,626 Added 9.68%	380,864 $56.4 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $409,805 - $493,196	-3,004 Reduced 0.86%	347,238 $57 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $609,178 - $753,989	-5,117 Reduced 1.44%	350,242 $48.6 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $3.19 Million - $3.95 Million	29,864 Added 9.17%	355,359 $46.7 Million
Q3 2019 Nov 19, 2019	BUY	$106.79 - $116.16 $14,309 - $15,565	134 Added 0.04%	325,495 $36.4 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $4.38 Million - $4.76 Million	-41,017 Reduced 11.2%	325,361 $36.4 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $9.09 Million - $10.6 Million	82,005 Added 28.84%	366,378 $40.6 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $8.68 Million - $10.2 Million	-77,988 Reduced 21.52%	284,373 $36.9 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $3.76 Million - $4.21 Million	35,500 Added 10.86%	362,361 $42 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $6.21 Million - $7.76 Million	-72,290 Reduced 18.11%	326,861 $35.1 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $1 Million - $1.15 Million	-13,249 Reduced 3.21%	399,151 $34.2 Million
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $15 Million - $17.7 Million	-201,823 Reduced 32.86%	412,400 $31.9 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $1.84 Million - $1.97 Million	22,428 Added 3.79%	614,223 $51.8 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $45.6 Million - $50.6 Million	591,795	591,795 $0

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Eli Lilly & CO Transaction History